Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Antidiabetic activity of beta3-adrenoceptor agonist BRL-37344 elucidated in vitro

Sep. 19, 1997

U.S. introduction for FemPatch

Sep. 18, 1997

Dopamine D1/D2 coactivation maximizes metabolic responses in obese mice

Sep. 18, 1997

TheraTech and Astra sign agreement for Androderm distribution

Sep. 18, 1997

New raloxifene analogue from Lilly is a potent SERM

Sep. 18, 1997

Novel osteoclast resorption inhibitor isolated by Swiss investigators

Sep. 18, 1997

Known antidiabetic agent modulates glucocorticoid response in osteoclasts

Sep. 18, 1997

Role of osteoprotegerin in skeletal metabolism elucidated

Sep. 18, 1997

Separation of antiobesity and antidiabetic effects of beta3-adrenoceptor agonist established in rats

Sep. 18, 1997

Growth hormone antagonist enters phase II

Sep. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...